Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR, et al. Pregnancy-associated plasma protein a as a marker of acute coronary syndromes. N Engl J Med 2001;345:1022–9.PubMedCrossrefGoogle Scholar
Harrington SC, Simari RD, Conover CA. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circ Res 2007;100:1696–702.PubMedWeb of ScienceCrossrefGoogle Scholar
Tuunainen E, Lund J, Danielsson J, Pietilä P, Wahlroos V, Pudge K, et al. Direct immunoassay for free pregnancy-associated plasma protein A (PAPP-A). J Appl Lab Med 2018;3:438–49.CrossrefGoogle Scholar
Lund J, Wittfooth S, Qin QP, Ilva T, Porela P, Pulkki K, et al. Free vs total pregnancy-associated plasma protein A (PAPP-A) as a predictor of 1-year outcome in patients presenting with non-ST-elevation acute coronary syndrome. Clin Chem 2010;56:1158–65.Web of ScienceCrossrefPubMedGoogle Scholar
Laursen LS, Overgaard MT, Weyer K, Boldt HB, Ebbesen P, Christiansen M, et al. Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. Reversible adhesion is mediated by two neighboring short consensus repeats. J Biol Chem 2002;277:47225–34.CrossrefPubMedGoogle Scholar
Tertti R, Wittfooth S, Porela P, Airaksinen KE, Metsärinne K, Pettersson K. Intravenous administration of low molecular weight and unfractionated heparin elicits a rapid increase in serum pregnancy-associated plasma protein A. Clin Chem 2009;55:1214–7.Web of SciencePubMedCrossrefGoogle Scholar
Wittfooth S, Tertti R, Lepantalo M, Porela P, Qin Q-P, Tynjala J, et al. Studies on the effects of heparin products on pregnancy-associated plasma protein A. Clin Chim Acta 2011;412:376–81.Web of ScienceCrossrefPubMedGoogle Scholar
Jespersen CH, Vestergaard KR, Schou M, Teisner B, Iversen K. The effect of heparin on pregnancy associated plasma protein-A concentration in healthy, non-pregnant individuals. Clin Biochem 2015;48:757–61.PubMedCrossrefWeb of ScienceGoogle Scholar
Uusitalo V, Kamperidis V, de Graaf MA, Maaniitty T, Stenstrom I, Broersen A, et al. Coronary computed tomography angiography derived risk score in predicting cardiac events. J Cardiovasc Comput Tomogr 2017;11:274–80.PubMedWeb of ScienceCrossrefGoogle Scholar
About the article
Published Online: 2018-11-09
Published in Print: 2019-06-26
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This work was supported by The Academy of Finland Centre of Excellence on Cardiovascular and Metabolic Disease, Helsinki, Finland (AS and JK), the Finnish Foundation for Cardiovascular Research (AS and JK) and University of Turku Doctoral Programme of Clinical Research (ET). For TM, KP and SW none declared.
Employment or leadership: None declared.
Honorarium: Outside the submitted work consultancy for GE Healthcare, Novartis and Astra Zeneca (AS), payment for lectures from Bayer, Abbott and Actelion (AS) and personal fees from Astra Zeneca (JK). For ET, TM, KP and SW none declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.